source
- Beren Therapeutics secures $300 million to fund rare disease drug launch ahead of FDA reviewBeren Therapeutics announced it has raised $300 million in new financing to support the development and launch of its rare disease therapy. The funding arrives as the company prepares for an FDA d…
- Ethyreal Bio raises $101M to develop antibody targeting Graves disease and thyroid eye diseaseEthyreal Bio, a Cambridge-based biotech that has just emerged from stealth mode, announced it has closed a $101 million financing round to advance its lead candidate. The company’s candidate, a mo…